A B S T R A C T A method for isolating human hemoglobin messenger RNA (mRNA) from bone marrow cells was developed to investigate the molecular basis for the defect in globin synthesis in beta thalassemia. Active mRNA was isolated from the bone marrow cells and peripheral reticulocytes of patients with homozygous beta thalassemia, heterozygous beta thalassemia, sickle cell trait, double heterozygosity for beta thalassemia and sickle cell trait, as well as from a patient with normal hemoglobin synthesis but with an elevated reticulocyte count secondary to hereditary spherocytosis. The mRNA was prepared for assay in an mRNA-dependent rabbit reticulocyte cell-free system and the amount of alpha and beta globin chains synthesized was determined by carboxymethylcellulose column chromatography. The relative synthesis of alpha to beta chains in response to normal hemoglobin mRNA was found to be a function of the amount of mRNA added to the assay system: increasing the amount of mRNA led to a decrease in the alpha-to-beta-chain synthetic ratio. Therefore, assays were carried out at limiting concentrations of mRNA.
The molecular defect in homozygous beta thalassemia was shown to be carried in the mRNA of bone marrow cells as well as in the mRNA from peripheral reticulocytes, because much less beta than alpha globin was produced in the cell-free system in response to mRNA from either type of cell. In patients doubly heterozygous for beta thalassemia and sickle cell trait, little or no synthesis of betaA globin occurred in the bone marrow cells or the peripheral reticulocytes. The alpha to betas synthetic ratio of the intact bone marrow cells was approximately 1, while the same ratio in the peripheral reticulocytes was between 1.5 and 2. The virtual absence of translatable beta globin mRNA in the mRNA prepared INTRODUCTION Beta thalassemia is an hereditary hemolytic anemia characterized by a deficiency or absence of synthesis of beta globin (1) (2) (3) (4) (5) , one of the polypeptide subunits of the hemoglobin molecule. This defect in beta globin synthesis occurs in the bone marrow erythroid cells as well as in the peripheral reticulocytes of patients homozygous for beta thalassemia (6) , although the deficiency in beta chain synthesis appears to be less marked in the bone marrow cells as compared to the peripheral blood reticulocytes. Hemoglobin synthesis in peripheral reticulocytes of patients heterozygous for beta thalassemia is characterized by a 35-50% reduction in beta chain relative to alpha chain synthesis (3) , but in the bone marrow cells of these patients an alpha/beta chain ratio of close to 1 is observed (7, 8) . The molecular mechanism responsible for the apparent decrease in the relative rate of synthesis of beta globin during maturation of the beta thalassemia erythroid cells has not yet been defined.
We have previously reported isolation of hemoglobin messenger RNA (mRNA)' from reticulocytes of patients with homozygous beta thalassemia and described its translation into protein in a cell-free system capable of synthesizing complete alpha and beta globin chains (9) . A marked deficiency in beta chain synthesis occurs Methods. Hematological parameters were determined by standard methods (13) . Percent Hb As was determined by DEAE-cellulose chromatography (14) , and percent Hb F by alkali denaturation (15) . Bone marrow was obtained from the posterior iliac spine of each patient. Three or four aspirates yielded 6-8 cc of marrow containing a total of 2-10 X 108 nucleated cells. The percentage of the total nucleated cells that were erythroid precursors varied from 20 to 75%o depending on the degree of marrow erythroid hyperplasia. There were 2540% as many reticulocytes as total nucleated erythroid cells. The marrow from each aspirate was collected in a syringe containing 10 ml of minimal essential Eagle's media (MEM) (16) , with 400 U of heparin/ml. The aspirates were pooled, mixed, and portions retained for nucleated cell counts and whole cell incubations. The remainder was used for the extraction of globin mRNA.
Extraction of globin mRNA from human bone marrow cells. 2-9 X 10' nucleated bone marrow cells suspended in approximately 40 ml of heparinized MEM were added in drops to a rapidly stirred phenol-buffer mixture at room temperature. This mixture consisted of 40 ml of acetate buffer (0.5 M sodium acetate (pH 5.0), 0.1 M NaCl, 0.01 M EDTA, and 0.5% sodium dodecyl sulfate) and 80 ml of reagent grade phenol previously saturated with the acetate buffer. Recovery of the aqueous phase, reextraction of the phenol phase at 560C with acetate buffer, and recovery of RNA by ethanol precipitation was performed exactly as described previously for the preparation of globin RNA from sheep and goat bone marrow cells (17) , except that chloroform was omitted. The RNA was fractionated by sucrose gradient centrifugation, and a 9-10S fraction collected, concentrated by ethanol precipitation, and prepared for assay in the cell-free system as previously described (9, 12, 17) .
Extraction of globin mRNA from peripheral reticulocytes. Preparation of membrane-free lysates from peripheral blood (18, 19) , phenol extraction of total cellular RNA, sucrose gradient centrifugation of RNA, and preparation of the mRNA (9-10 S) fraction for assay in the cell-free system have been previously described (9, 12) .
Cell-free protein synthesis in the mRNA-dependent assay (A) Total activity. Assays were performed in a standard 0.1-ml incubation mixture as described in Methods. (B) Alpha/beta globin chain ratio synthesized at various mRNA concentrations. The human globin product was chromatographed on a carboxymethylcellulose column and the ratio of total radioactivity incorporated into alpha and beta chains was calculated (See Methods).
system. All biological components of the assay system except for mRNA were prepared from reticulocytes (18) obtained from rabbits injected with phenylhydrazine. Ribosomes were freed of rabbit globin mRNA by mild ribonuclease treatment (9, 12) . The methods for preparation of (a) the ribosomal wash fraction containing the protein synthesis initiation factors, (b) the S-100 supernatant fraction containing the aminoacyl transfer RNA (tRNA) synthetases and the protein synthesis elongation factors, and (c) the unfractionated reticulocyte tRNA have been previously described (12, 18) . Assay of the mRNA fractions was performed in a standard 0.10-ml reaction mixture containing 20 mM Tris-HCl (pH 7.5), 3 Amo, U/0.10 ml reaction mixture) in order to determine the amount of RNA that produced maximal activity (satu- (18, 19) . Product analysis of globin chains synthesized iln tile cellfree assay system. To analyze the products of the cell-free assay system, the size of the reaction mixture was increased 3-15 fold. The concentration of all reactants was unchanged.
['H]leucine (specific activity 51 Ci/mmole) was substituted for ["C]leucine. The incubations for product analysis were run at rate-limiting amounts of mRNA. The amount of mRNA tested and the percentage this amount represented of that required to give maximum protein synthesis (percent saturation) is given in Figs. 3 and 4 and in Table II . Each column was run as a double-label experiment comparing the products of the cell-free assay system (labeled with 3H) to the corresponding products of a whole cell incubation (labeled with "C). The uniformly labeled globin chains obtained from whole cell incubations provided an internal control for calculating alpha/beta globin chain ratios (Table  II) . The globin chains were separated by carboxymethylcellulose column chromatography in 8 M urea-phosphate buffer after preparation of the globin by acid-acetone extraction of heme (12, 19, 20) . The conditions of chromatography permitted separation of all the radioactive rabbit globin from the human alpha peak (12) . The radioactivity in the column fractions was quantitated by standard doublelabel counting techniques. 0.75 ml of each fraction, 0.75 ml of water, and 15 ml of Triton X-100 in Liquifluor were mixed in a scintillation vial and counted directly. The efficiency for 'H was 16% and for "C was 56%. The alpha/ beta globin chain ratios were calculated by summing the total counts in each peak after correcting the 3H counts per minute for the "C contribution. RESULTS Globin mRNA was recovered from both total bone marrow cells and peripheral reticulocytes and tested in the cell-free assay system (see Methods) . The relationship between the alpha/beta synthetic ratio and the concentration of normal reticulocyte mRNA added to the cell-free assay system was determined. At limiting mRNA, the alpha/beta ratio is close to 1 (Fig. 2A) ; at saturating mRNA it is about 0.3-0. 4 (Fig. 2B) ; and at inhibiting concentrations of mRNA, the ratio drops to 0.1 (Fig. 2C) . The full range of alpha/beta ratios is plotted in Fig. 1B . Similar data were obtained with normal bone marrow mRNA (Table II) and had previously been found with rabbit globin mRNA. Thus, for the alpha/beta globin chain ratio in the cell-free assay system to reflect the ratio found in the intact normal cell, the concentration of mRNA assayed in the cell-free system must be below 30% saturation. The data obtained with mRNA preparations extracted from abnormal cells and assayed at various concentrations also demonstrate these observations (Table II The alpha/beta globin chain ratio was measured in each patient (Table I) , both in intact cells by whole cell incubation and in the cell-free system in response to globin mRNA isolated from the bone marrow cells and peripheral reticulocytes (see Table II ). In the two patients with homozygous beta thalassemia, a marked decrease in beta chain synthesis was evident in both marrow cells and peripheral reticulocytes. mRNA extracted from each of these cell populations reflected the same alpha/beta globin chain imbalance (Fig. 3) . Little or no betaA globin synthesis was demonstrated by whole cell incubations or in the cell-free system in response to mRNA isolated from the cells of the two patients with sickle-thalassemia (Fig. 4) . However, the alpha/beta8 ratios were different. Intact cells from the bone marrow produced equal amounts of alpha and beta' chains; in the cell-free system at rate-limiting concentrations of bone marrow mRNA, an excess of alpha globin was produced. The peripheral reticulocytes of these patients had an alpha/beta' synthetic ratio of 1.6-1.7 in the whole cell incubation, and 2.3-2.6 in the cell-free system in response to reticulocyte globin mRNA, while the corresponding ratio for bone marrow cells was close to 1 (Table II) . This disparity in synthesis of globin by intact cells of the bone marrow and peripheral reticulocytes is similar to that seen in the beta thalassemia heterozygote: the alpha/beta synthetic ratio of bone marrow was nearly 1, but that of reticulocytes was approximately 2.0 (Fig. 5) . The alpha/beta ratios in the cell-free system at rate-limiting concentration of this patient's bone marrow mRNA were greater than 1 and were considerably higher than those obtained with normal bone marrow mRNA at equivalent concentrations (Table II) .
DISCUSSION
Globin mRNA, extracted from the bone marrow erythroid cells of patients with homozygous beta thalassemia, directed the synthesis of a large excess of alpha compared with beta globin in the cell-free system. This disparity in alpha/beta chain synthesis was comparable to the disparity seen during whole cell incubation. Since 75-90% of total red cell hemoglobin is produced in the nucleated marrow erythroid cells (11) , this observation was necessary to confirm the interpretation, based on studies with reticulocyte globin mRNA, that the molecular defect in homozygous beta thalassemia is a reduction in the amount of functional beta globin mRNA (9, 10) . Two interesting observations have been obtained from the study of double heterozygotes with sicklethalassemia. Little or no betaA globin synthesis was detected in the intact erythroid cells of these patients, and little or no translatable betaA globin mRNA was found after extraction of the RNA from these cells. This observation suggests that in the type of beta thalassemia characterized by very low or absent betaA synthesis, the molecular defect is also carried by the beta globin mRNA.
Conconi, Rowley, Del Senno, and Pontremoli, however, have obtained data using a cell-free system of low activity which they interpret to suggest that patients homozygous for thalassemia with zero betaA production (Ferrara type) have normal betaA globin mRNA but are missing a factor present in normal human reticulocyte lysates (21) . Similar experiments performed by Rowley and Rosciolek in studies of patients with homozygous beta thalassemia who produce some beta chain have shown no alteration in the alpha/beta ratio in the cell-free system (22) , confirming our previous results obtained in a highly active cell-free system derived from rabbit reticulocytes (19) . It would be of interest to examine directly the bone marrow globin mRNA of patients with Ferraratype homozygous beta thalassemia in an active cell-free system to see if a normal amount of translatable betaA globin mRNA is present despite the lack of betaA globin synthesis by the intact cells.
A second observation derived from the study of the sickle-thalassemia patients bears on the apparent disparity between the alpha/beta synthetic ratio in bone marrow cells and peripheral reticulocytes. This disparity would not seem to be a direct result of the beta thalassemia gene since betae globin synthesis is essentially absent in both marrow cells and peripheral reticulocytes, and yet the alpha/betas ratio is much closer to 1 in the intact bone marrow cells of these doubly heterozygous patients than in their peripheral reticulocytes. An apparently balanced synthesis of globin occurs at the expense of total reduction of hemoglobin synthesis, because the cells of these patients are hypochromic and microcytic (Table I) . Recently, Gill, Atwater, and Schwartz have shown that a similar phenomenon exists in patients heterozygous Jfor Hb Lepore: alpha/beta globin chain synthesis is close to 1 in the bone marrow of these/ patients while unbalanced synthesis occurs in the peripheral reticulocytes even though there is very little Hb Lepore produced in either cell type (23) .
Detection of a small pool of excess alpha chains in the marrow of heterozygous beta thalassemia patients indicates that globin synthesis is not completely balanced (24) . In addition, the presence of an unknown marrow protein eluting with the beta globin chain from carboxymethylcellulose columns may further complicate the picture (24) . Nevertheless, the evidence indicates that bone marrow cells can achieve more closely balanced globin synthesis than occurs in the normal hemoglobin synthesis and that of the two patients doubly heterozygous for beta thalassemia and sickle cell trait. The alpha/beta ratio of the normal mRNA is equal to or less than that of the intact reticulocyte, while the alpha/beta ratio of the double heterozygote mRNA exceeds that of the corresponding intact cell. This may imply again a relative excess of alpha mRNA in these cells, the translation of which is retarded. Similar comparisons between the intact cells and mRNA preparations of the patients with homozygous thalassemia do not show any consistent differences, perhaps because of the very small amount of functional beta mRNA present. The difference in alpha/beta ratio between bone marrow cells and reticulocytes of our homozygous patients was less than the average found by Braverman and Bank (6), but there was a considerable range in this parameter among the patients they studied. Several factors influencing the relative amount of alpha and beta globin chain synthesis have been identified in cell-free systems (18, (25) (26) (27) (28) , but whether any of these is operative in intact erythroid cells is unknown. Such knowledge might be of value, however, because deliberate reduction of alpha chain synthesis, producing more nearly balanced synthesis of globin chains, might reduce the severity of the disease in the beta thalassemia homozygote (29) .
